Uniphar plc
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a UPR.L research report →
Companywww.uniphar.ie
Uniphar plc operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, and internationally. The company operates through three divisions: Commercial & Clinical, Product Access, and Supply Chain & Retail. The Commercial & Clinical division offers outsourced sales, marketing, and multichannel account management services to pharmaco-medical manufacturers; and distribution and support services to medical device manufacturers.
- CEO
- Gerard Rabbette
- IPO
- 2019
- Employees
- 3,500
- HQ
- Dublin, IE
Price Chart
Valuation
- Market Cap
- $1.03B
- P/E
- 23.21
- P/S
- 0.39
- P/B
- 2.93
- EV/EBITDA
- 14.03
- Div Yield
- 0.44%
Profitability
- Gross Margin
- 14.89%
- Op Margin
- 2.79%
- Net Margin
- 1.66%
- ROE
- 13.14%
- ROIC
- 7.57%
Growth & Income
- Revenue
- $3.07B · 10.95%
- Net Income
- $51.07M · -20.45%
- EPS
- $0.19 · -20.83%
- Op Income
- $91.11M
- FCF YoY
- 282.61%
Performance & Tape
- 52W High
- $400.00
- 52W Low
- $282.00
- 50D MA
- $349.02
- 200D MA
- $337.33
- Beta
- 1.13
- Avg Volume
- 192.44K
Get TickerSpark's AI analysis on UPR.L
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our UPR.L Coverage
We haven't published any research on UPR.L yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate UPR.L Report →